BioCentury
ARTICLE | Company News

FDA approves GSK's H5N1 avian flu vaccine

November 23, 2013 2:28 AM UTC

FDA approved the adjuvanted Influenza A (H5N1) Virus Monovalent Vaccine from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to prevent H5N1 influenza in adults who are at increased risk of exposure to the vi...